Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Opportunities for High-plex Spatial Transcriptomics in Solid Organ Transplantation.

Cross AR. et al, (2023), Transplantation, 107, 2464 - 2472

Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury.

Cross AR. et al, (2023), JCI Insight, 8

A GMP Protocol for the Manufacture of Tregs for Clinical Application.

O'Neil A. et al, (2023), 2559, 205 - 227

Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism.

Cavounidis A. et al, (2022), Mucosal Immunol

Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection.

VanDyke D. et al, (2022), Cell Rep, 41

Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans.

Lim TY. et al, (2022), J Hepatol

Regulatory T cell therapy approaches.

McCallion O. et al, (2022), Clin Exp Immunol

Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis.

Shankar S. et al, (2022), Nat Commun, 13

SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients.

Shankar S. et al, (2022), J Am Soc Nephrol, 33, 883 - 887

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients.

Brook MO. et al, (2022), BMJ Open, 12

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients

Bottomley MJ. et al, (2022)

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.

Fletcher CE. et al, (2022), Mol Cancer, 21

Chimeric Antigen Receptors and Regulatory T Cells: The Potential for HLA-Specific Immunosuppression in Transplantation

Wright S. et al, (2022), ENGINEERING, 10, 30 - 43

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients.

Bottomley MJ. et al, (2022), Front Immunol, 13

Towards regulatory cellular therapies in solid organ transplantation.

Bottomley MJ. et al, (2022), Trends Immunol, 43, 8 - 21

Chimeric antigen receptors and regulatory T cells: the potential for HLA-directed immunosuppression in transplantation

ISSA F. et al, (2021), Engineering

Biomarkers and Surrogates of Acute Rejection in Vascularized Composite Allograft Transplantation

ISSA F. et al, (2021), Reconstructive Transplantation and Regenerative Medicine The Emerging Interface

Poor Antibody Responses to SARS-CoV-2 Infection or Vaccination Are Associated With High Re-Infection Rates in Haemodialysis and Renal Transplant Patients

Beckett J. et al, (2021)

Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73.

Jarvis LB. et al, (2021), Commun Biol, 4

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.

Carr EJ. et al, (2021), Lancet, 398, 1038 - 1041

Load More

1
2
3
4
5
6

Include forthcoming?